Publications:

Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.

Esmo Open

Park, H H; Shapiro, G I GI; Gao, X X; Mahipal, A A; Starr, J J; Furqan, M M; Singh, P P; Ahrorov, A A; Gandhi, L L; Ghosh, A A; Hickman, D D; Gallacher, P D PD; Wennborg, A A; Attar, E C EC; Awad, M M MM; Das, S S; Dumbrava, E E EE

Publication Date: 2022-10

Variant appearance in text: DOT1L: V173L

PubMed Link: 36084396

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page